CJC-1295 + Ipamorelin — the most-cited growth-hormone secretagogue research stack in US laboratory literature.
CJC-1295 and ipamorelin are commonly studied together because they engage complementary growth-hormone secretagogue pathways. CJC-1295 is a GHRH analog; ipamorelin is a selective GHSR agonist.
Why the combination is studied together
- GHRH-axis stimulation (CJC-1295)
- Ghrelin-axis stimulation (ipamorelin) without prolactin or cortisol elevation in published rodent literature
- Independent mechanisms allow co-administration in pharmacokinetic studies
Research use only. 3 Diamond Labs supplies materials strictly for in vitro and laboratory research. Nothing in this article constitutes medical, therapeutic, or dosage advice for human or animal use.
